Modulation of HIVGP120 Antigen-Specific Immune Responses In Vivo by Δ9-Tetrahydrocannabinol

[1]  N. Kaminski,et al.  Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[2]  S. Simmons,et al.  Magnitude of stimulation dictates the cannabinoid‐mediated differential T cell response to HIVgp120 , 2012, Journal of leukocyte biology.

[3]  P. Molina,et al.  Cannabinoid administration attenuates the progression of simian immunodeficiency virus. , 2011, AIDS research and human retroviruses.

[4]  P. Molina,et al.  Tolerance to chronic delta-9-tetrahydrocannabinol (Δ⁹-THC) in rhesus macaques infected with simian immunodeficiency virus. , 2011, Experimental and clinical psychopharmacology.

[5]  Stephen P. H. Alexander,et al.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 , 2010, Pharmacological Reviews.

[6]  N. Letvin,et al.  X4 Human Immunodeficiency Virus Type 1 gp120 Down-Modulates Expression and Immunogenicity of Codelivered Antigens , 2009, Journal of Virology.

[7]  Norman L. Letvin,et al.  T-Cell Vaccine Strategies for Human Immunodeficiency Virus, the Virus with a Thousand Faces , 2009, Journal of Virology.

[8]  N. Kaminski,et al.  Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Δ9‐tetrahydrocannabinol , 2008, Journal of leukocyte biology.

[9]  R. Hill,et al.  Cannabinoids Affect Dendritic Cell (DC) Potassium Channel Function and Modulate DC T Cell Stimulatory Capacity1 , 2008, The Journal of Immunology.

[10]  Dennis R. Burton,et al.  Toward an AIDS Vaccine , 2008, Science.

[11]  W. Hsu,et al.  A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells. , 2008, International immunopharmacology.

[12]  S. Landry,et al.  Antigen structure influences helper T‐cell epitope dominance in the human immune response to HIV envelope glycoprotein gp120 , 2008, European journal of immunology.

[13]  N. Kaminski,et al.  Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Δ9‐tetrahydrocannabinol , 2008, Journal of leukocyte biology.

[14]  N. Kaminski,et al.  Modulation of Airway Responses to Influenza A/PR/8/34 by Δ9-Tetrahydrocannabinol in C57BL/6 Mice , 2007, Journal of Pharmacology and Experimental Therapeutics.

[15]  W. Jacobs,et al.  Genetic Alteration of Mycobacterium smegmatis To Improve Mycobacterium-Mediated Transfer of Plasmid DNA into Mammalian Cells and DNA Immunization , 2007, Infection and Immunity.

[16]  S. Werner,et al.  Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid System , 2007, Science.

[17]  S. Heller,et al.  Protease-Activated Receptors: Mechanisms by Which Proteases Sensitize TRPV Channels to Induce Neurogenic Inflammation and Pain -- TRP Ion Channel Function in Sensory Transduction and Cellular Signaling Cascades , 2006 .

[18]  N. Kaminski,et al.  Cannabinoid-Mediated Elevation of Intracellular Calcium: A Structure-Activity Relationship , 2006, Journal of Pharmacology and Experimental Therapeutics.

[19]  C. Newton,et al.  Role of cannabinoid receptors in Delta-9-tetrahydrocannabinol suppression of IL-12p40 in mouse bone marrow-derived dendritic cells infected with Legionella pneumophila. , 2006, European journal of pharmacology.

[20]  H. Robinson,et al.  T cell vaccines for microbial infections , 2005, Nature Medicine.

[21]  L. Busch,et al.  Expression and biological effects of CB1 cannabinoid receptor in rat parotid gland. , 2004, Biochemical pharmacology.

[22]  Michael Pennington,et al.  K+ channels as targets for specific immunomodulation. , 2004, Trends in pharmacological sciences.

[23]  D. Israelski,et al.  Patterns of Marijuana Use Among Patients With HIV/AIDS Followed in a Public Health Care Setting , 2004, Journal of acquired immune deficiency syndromes.

[24]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[25]  Scott A. Brown,et al.  Clustering of Th Cell Epitopes on Exposed Regions of HIV Envelope Despite Defects in Antibody Activity 1 , 2003, The Journal of Immunology.

[26]  N. Kaminski,et al.  Evidence for Cannabinoid Receptor-Dependent and -Independent Mechanisms of Action in Leukocytes , 2003, Journal of Pharmacology and Experimental Therapeutics.

[27]  N. Kaminski,et al.  Attenuation of the ovalbumin-induced allergic airway response by cannabinoid treatment in A/J mice. , 2003, Toxicology and applied pharmacology.

[28]  M. Herkenham,et al.  International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors , 2002, Pharmacological Reviews.

[29]  N. Kaminski,et al.  Cannabinol enhancement of interleukin-2 (IL-2) expression by T cells is associated with an increase in IL-2 distal nuclear factor of activated T cell activity. , 2002, Molecular pharmacology.

[30]  M. Kuroda,et al.  Potent CD4+ T Cell Responses Elicited by a Bicistronic HIV-1 DNA Vaccine Expressing gp120 and GM-CSF1 , 2002, The Journal of Immunology.

[31]  R. Tuskan,et al.  Stimulation of HIV gp120-specific cytolytic T lymphocyte responses in vitro and in vivo using a detoxified pertussis toxin vector. , 2001, AIDS research and human retroviruses.

[32]  N. Kaminski,et al.  Role of mitogen‐activated protein kinases in the differential regulation of interleukin‐2 by cannabinol , 2001, Journal of leukocyte biology.

[33]  A. Capron,et al.  Modulation of cellular and humoral immune responses to a multiepitopic HIV-1 DNA vaccine by interleukin-18 DNA immunization/viral protein boost. , 2001, Vaccine.

[34]  P. Doherty,et al.  Localization of CD4+ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Heishman,et al.  Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. , 2001, Archives of general psychiatry.

[36]  C. Locht,et al.  Interleukin-18 modulates immune responses induced by HIV-1 Nef DNA prime/protein boost vaccine. , 2000, Vaccine.

[37]  C. Newton,et al.  Δ9-Tetrahydrocannabinol Treatment Suppresses Immunity and Early IFN-γ, IL-12, and IL-12 Receptor β2 Responses to Legionella pneumophila Infection1 , 2000, The Journal of Immunology.

[38]  D. Julius,et al.  Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide , 1999, Nature.

[39]  P. Ferrara,et al.  Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor. , 1999, European journal of pharmacology.

[40]  M. Essex,et al.  Hypervariable region 3 residues of HIV type 1 gp120 involved in CCR5 coreceptor utilization: therapeutic and prophylactic implications. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  G. Martin,et al.  Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses. , 1998, The Journal of pharmacology and experimental therapeutics.

[42]  J. Brotchie,et al.  Paradoxical action of the cannabinoid WIN 55,212‐2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices , 1997, British journal of pharmacology.

[43]  N. Kaminski,et al.  Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. , 1997, Toxicology and applied pharmacology.

[44]  C. Eder,et al.  Voltage‐gated K+ currents of mouse dendritic cells , 1995, FEBS letters.

[45]  K. Mackie,et al.  Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. , 1995, Molecular pharmacology.

[46]  D. Ho,et al.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.

[47]  S. Munro,et al.  Molecular characterization of a peripheral receptor for cannabinoids , 1993, Nature.

[48]  S. Heishman,et al.  Marijuana smoking: effect of varying delta 9-tetrahydrocannabinol content and number of puffs. , 1992, The Journal of pharmacology and experimental therapeutics.

[49]  Tsonwin Hai,et al.  Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[50]  T. Bonner,et al.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA , 1990, Nature.

[51]  L. Glimcher,et al.  A cDNA for a human cyclic AMP response element-binding protein which is distinct from CREB and expressed preferentially in brain. , 1990, Molecular and cellular biology.

[52]  J. Berzofsky,et al.  Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes. , 1989, Journal of immunology.

[53]  L. Harris,et al.  Effect of δ9-Tetrahydrocannabinol on Herpes Simplex Virus Type 2 Vaginal Infection in the Guinea Pig , 1986, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[54]  R. Mechoulam,et al.  Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish , 1964 .

[55]  L. Morris,et al.  The Antibody Response against HIV-1. , 2012, Cold Spring Harbor perspectives in medicine.

[56]  N. Kaminski,et al.  Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Delta9-tetrahydrocannabinol. , 2008, Journal of leukocyte biology.

[57]  S. Simon,et al.  TRPV1 Receptors and Signal Transduction , 2007 .

[58]  S. Heller,et al.  TRPV1 Receptors and Signal Transduction -- TRP Ion Channel Function in Sensory Transduction and Cellular Signaling Cascades , 2007 .

[59]  John M. Walker,et al.  DNA Vaccines , 2006, Methods in Molecular Medicine™.

[60]  C. Newton,et al.  Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophila infection. , 2000, Journal of immunology.

[61]  Li Zhu,et al.  D-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway , 2000 .

[62]  T. Klein,et al.  Contrasting effects of THC on adult murine lymph node and spleen cell populations stimulated with mitogen or anti-CD3 antibody. , 1992, Immunopharmacology and immunotoxicology.